166 related articles for article (PubMed ID: 9747435)
21. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts.
Liu Y; Tsuchida A; Cohen MV; Downey JM
J Mol Cell Cardiol; 1995 Mar; 27(3):883-92. PubMed ID: 7602606
[TBL] [Abstract][Full Text] [Related]
22. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts.
Goto M; Liu Y; Yang XM; Ardell JL; Cohen MV; Downey JM
Circ Res; 1995 Sep; 77(3):611-21. PubMed ID: 7641331
[TBL] [Abstract][Full Text] [Related]
23. [Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts].
Liu JC; Kang J; Shao LJ; He M
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):987-91. PubMed ID: 16759542
[TBL] [Abstract][Full Text] [Related]
24. Equal reduction in infarct size by ethylisopropyl-amiloride pretreatment and ischemic preconditioning in the in situ rabbit heart.
Munch-Ellingsen J; Løkebø JE; Bugge E; Ytrehus K
Mol Cell Biochem; 1998 Sep; 186(1-2):13-8. PubMed ID: 9774180
[TBL] [Abstract][Full Text] [Related]
25. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits.
Miki T; Cohen MV; Downey JM
Mol Cell Biochem; 1998 Sep; 186(1-2):3-12. PubMed ID: 9774179
[TBL] [Abstract][Full Text] [Related]
26. Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(-)-N6-(2-phenylisopropyl)adenosine is related to defect at the adenosine A1 receptor.
Hashimi MW; Thornton JD; Downey JM; Cohen MV
Mol Cell Biochem; 1998 Sep; 186(1-2):19-25. PubMed ID: 9774181
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart.
Wang P; Gallagher KP; Downey JM; Cohen MV
J Mol Cell Cardiol; 1996 Mar; 28(3):579-88. PubMed ID: 9011641
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide as a mediator of delayed pharmacological (A(1) receptor triggered) preconditioning; is eNOS masquerading as iNOS?
Bell RM; Smith CC; Yellon DM
Cardiovasc Res; 2002 Feb; 53(2):405-13. PubMed ID: 11827691
[TBL] [Abstract][Full Text] [Related]
29. A novel cardioprotective agent, JTV-519, is abolished by nitric oxide synthase inhibitor on myocardial metabolism in ischemia-reperfused rabbit hearts.
Kawabata H; Nakagawa K; Ishikawa K
Hypertens Res; 2002 Mar; 25(2):303-9. PubMed ID: 12047047
[TBL] [Abstract][Full Text] [Related]
30. Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation.
Yang XM; Sato H; Downey JM; Cohen MV
J Mol Cell Cardiol; 1997 Mar; 29(3):991-9. PubMed ID: 9152860
[TBL] [Abstract][Full Text] [Related]
31. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning.
Gelpi RJ; Morales C; Cohen MV; Downey JM
Basic Res Cardiol; 2002 Jan; 97(1):40-6. PubMed ID: 11998976
[TBL] [Abstract][Full Text] [Related]
32. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart.
Baines CP; Wang L; Cohen MV; Downey JM
J Mol Cell Cardiol; 1998 Feb; 30(2):383-92. PubMed ID: 9515015
[TBL] [Abstract][Full Text] [Related]
33. The role of NO in ischemia/reperfusion injury in isolated rat heart.
Andelová E; Barteková M; Pancza D; Styk J; Ravingerová T
Gen Physiol Biophys; 2005 Dec; 24(4):411-26. PubMed ID: 16474186
[TBL] [Abstract][Full Text] [Related]
34. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
Tosaki A; Maulik N; Elliott GT; Blasig IE; Engelman RM; Das DK
J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433
[TBL] [Abstract][Full Text] [Related]
35. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes.
Miura T; Miura T; Kawamura S; Goto M; Sakamoto J; Tsuchida A; Matsuzaki M; Shimamoto K
Cardiovasc Res; 1998 Mar; 37(3):700-9. PubMed ID: 9659454
[TBL] [Abstract][Full Text] [Related]
36. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
[TBL] [Abstract][Full Text] [Related]
37. Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species dependence in the rat versus rabbit isolated heart.
Pabla R; Curtis MJ
J Mol Cell Cardiol; 1996 Oct; 28(10):2097-110. PubMed ID: 8930805
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release.
Cohen MV; Walsh RS; Goto M; Downey JM
J Mol Cell Cardiol; 1995 Aug; 27(8):1527-34. PubMed ID: 8523416
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts.
Weselcouch EO; Baird AJ; Sleph P; Grover GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H242-9. PubMed ID: 7530919
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotection by metformin is abolished by a nitric oxide synthase inhibitor in ischemic rabbit hearts.
Kawabata H; Ishikawa K
Hypertens Res; 2003 Jan; 26(1):107-10. PubMed ID: 12661919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
